Report on Extraordinary General Meeting in Neurosearch A/S
At the company's Extraordinary General Meeting today, the sale of Huntexil® to Teva Pharmaceutical Industries Ltd. through the fully owned affiliate Ivax International GmbH was approved by the general meeting.